25 XP   0   0   10

China Resources Pharmaceutical Group Ltd
Buy, Hold or Sell?

Let's analyse China Resources Pharmaceutical Group Ltd together

PenkeI guess you are interested in China Resources Pharmaceutical Group Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of China Resources Pharmaceutical Group Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about China Resources Pharmaceutical Group Ltd

I send you an email if I find something interesting about China Resources Pharmaceutical Group Ltd.

Quick analysis of China Resources Pharmaceutical Group Ltd (30 sec.)










What can you expect buying and holding a share of China Resources Pharmaceutical Group Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.08
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
HK$8.52
Expected worth in 1 year
HK$7.54
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
HK$-0.33
Return On Investment
-6.8%

For what price can you sell your share?

Current Price per Share
HK$4.88
Expected price per share
HK$4.56 - HK$5.34
How sure are you?
50%

1. Valuation of China Resources Pharmaceutical Group Ltd (5 min.)




Live pricePrice per Share (EOD)

HK$4.88

Intrinsic Value Per Share

HK$15.87 - HK$21.84

Total Value Per Share

HK$24.39 - HK$30.37

2. Growth of China Resources Pharmaceutical Group Ltd (5 min.)




Is China Resources Pharmaceutical Group Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$6.8b$7b-$196.1m-2.9%

How much money is China Resources Pharmaceutical Group Ltd making?

Current yearPrevious yearGrowGrow %
Making money$529.6m$481.2m$48.3m9.1%
Net Profit Margin1.6%1.6%--

How much money comes from the company's main activities?

3. Financial Health of China Resources Pharmaceutical Group Ltd (5 min.)




What can you expect buying and holding a share of China Resources Pharmaceutical Group Ltd? (5 min.)

Welcome investor! China Resources Pharmaceutical Group Ltd's management wants to use your money to grow the business. In return you get a share of China Resources Pharmaceutical Group Ltd.

What can you expect buying and holding a share of China Resources Pharmaceutical Group Ltd?

First you should know what it really means to hold a share of China Resources Pharmaceutical Group Ltd. And how you can make/lose money.

Speculation

The Price per Share of China Resources Pharmaceutical Group Ltd is HK$4.88. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of China Resources Pharmaceutical Group Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in China Resources Pharmaceutical Group Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$8.52. Based on the TTM, the Book Value Change Per Share is HK$-0.24 per quarter. Based on the YOY, the Book Value Change Per Share is HK$-5.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.16 per quarter.
Based on historical numbers we can estimate the returns while holding a share of China Resources Pharmaceutical Group Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.081.7%0.081.7%0.081.6%0.081.5%0.071.4%
Usd Book Value Change Per Share-0.03-0.6%-0.03-0.6%-0.64-13.1%-0.06-1.2%0.112.2%
Usd Dividend Per Share0.020.4%0.020.4%0.020.3%0.020.4%0.010.3%
Usd Total Gains Per Share-0.01-0.2%-0.01-0.2%-0.62-12.7%-0.04-0.9%0.122.5%
Usd Price Per Share0.81-0.81-0.45-0.80-0.64-
Price to Earnings Ratio9.57-9.57-5.92-10.61-9.08-
Price-to-Total Gains Ratio-76.61--76.61--0.73--20.40--13.19-
Price to Book Ratio0.74-0.74-0.40-0.60-0.49-
Price-to-Total Gains Ratio-76.61--76.61--0.73--20.40--13.19-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.623176
Number of shares1604
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share-0.03-0.06
Usd Total Gains Per Share-0.01-0.04
Gains per Quarter (1604 shares)-16.90-68.07
Gains per Year (1604 shares)-67.59-272.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1133-200-78110-382-282
2266-401-146220-764-554
3398-601-214329-1146-826
4531-801-282439-1528-1098
5664-1002-350549-1910-1370
6797-1202-418659-2292-1642
7929-1403-486768-2674-1914
81062-1603-554878-3056-2186
91195-1803-622988-3438-2458
101328-2004-6901098-3821-2730

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%7.03.00.070.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.01.090.0%9.00.01.090.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%7.03.00.070.0%7.03.00.070.0%

Fundamentals of China Resources Pharmaceutical Group Ltd

About China Resources Pharmaceutical Group Ltd

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biopharmaceutical drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular, alimentary tract, metabolism and endocrine, respiratory, orthopedics, oncology, medical nutrition, gastroenterology, pediatrics, genitourinary system, cough and cold, anti-infection, dermatology, infusion solutions, etc. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the CR Care and Teck Soon Hong brands. It distributes its products to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.

Fundamental data was last updated by Penke on 2024-04-16 19:40:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of China Resources Pharmaceutical Group Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit China Resources Pharmaceutical Group Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare China Resources Pharmaceutical Group Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 1.6% means that $0.02 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of China Resources Pharmaceutical Group Ltd:

  • The MRQ is 1.6%. The company is making a profit. +1
  • The TTM is 1.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.6%TTM1.6%0.0%
TTM1.6%YOY1.6%+0.0%
TTM1.6%5Y1.7%-0.1%
5Y1.7%10Y1.9%-0.1%
1.1.2. Return on Assets

Shows how efficient China Resources Pharmaceutical Group Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare China Resources Pharmaceutical Group Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.6% Return on Assets means that China Resources Pharmaceutical Group Ltd generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of China Resources Pharmaceutical Group Ltd:

  • The MRQ is 1.6%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.6%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.6%TTM1.6%0.0%
TTM1.6%YOY1.4%+0.2%
TTM1.6%5Y1.6%0.0%
5Y1.6%10Y1.9%-0.2%
1.1.3. Return on Equity

Shows how efficient China Resources Pharmaceutical Group Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare China Resources Pharmaceutical Group Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 7.7% Return on Equity means China Resources Pharmaceutical Group Ltd generated $0.08 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of China Resources Pharmaceutical Group Ltd:

  • The MRQ is 7.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.7%TTM7.7%0.0%
TTM7.7%YOY6.8%+0.9%
TTM7.7%5Y7.6%+0.1%
5Y7.6%10Y9.0%-1.4%

1.2. Operating Efficiency of China Resources Pharmaceutical Group Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient China Resources Pharmaceutical Group Ltd is operating .

  • Measures how much profit China Resources Pharmaceutical Group Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare China Resources Pharmaceutical Group Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 4.5% means the company generated $0.05  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of China Resources Pharmaceutical Group Ltd:

  • The MRQ is 4.5%. The company is operating less efficient.
  • The TTM is 4.5%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ4.5%TTM4.5%0.0%
TTM4.5%YOY4.2%+0.3%
TTM4.5%5Y5.0%-0.5%
5Y5.0%10Y5.6%-0.6%
1.2.2. Operating Ratio

Measures how efficient China Resources Pharmaceutical Group Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.79 means that the operating costs are $1.79 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of China Resources Pharmaceutical Group Ltd:

  • The MRQ is 1.791. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.791. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.791TTM1.7910.000
TTM1.791YOY1.799-0.009
TTM1.7915Y1.453+0.338
5Y1.45310Y1.195+0.257

1.3. Liquidity of China Resources Pharmaceutical Group Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if China Resources Pharmaceutical Group Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.25 means the company has $1.25 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of China Resources Pharmaceutical Group Ltd:

  • The MRQ is 1.250. The company is just able to pay all its short-term debts.
  • The TTM is 1.250. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.250TTM1.2500.000
TTM1.250YOY1.250+0.001
TTM1.2505Y1.238+0.013
5Y1.23810Y1.243-0.005
1.3.2. Quick Ratio

Measures if China Resources Pharmaceutical Group Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare China Resources Pharmaceutical Group Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.13 means the company can pay off $1.13 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of China Resources Pharmaceutical Group Ltd:

  • The MRQ is 1.126. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.126. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.126TTM1.1260.000
TTM1.126YOY1.164-0.038
TTM1.1265Y1.223-0.097
5Y1.22310Y1.039+0.184

1.4. Solvency of China Resources Pharmaceutical Group Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of China Resources Pharmaceutical Group Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare China Resources Pharmaceutical Group Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.79 means that China Resources Pharmaceutical Group Ltd assets are financed with 79.5% credit (debt) and the remaining percentage (100% - 79.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of China Resources Pharmaceutical Group Ltd:

  • The MRQ is 0.795. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.795. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.795TTM0.7950.000
TTM0.795YOY0.7950.000
TTM0.7955Y0.700+0.095
5Y0.70010Y0.677+0.023
1.4.2. Debt to Equity Ratio

Measures if China Resources Pharmaceutical Group Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare China Resources Pharmaceutical Group Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 386.9% means that company has $3.87 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of China Resources Pharmaceutical Group Ltd:

  • The MRQ is 3.869. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.869. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.869TTM3.8690.000
TTM3.869YOY3.876-0.007
TTM3.8695Y3.286+0.583
5Y3.28610Y3.290-0.004

2. Market Valuation of China Resources Pharmaceutical Group Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings China Resources Pharmaceutical Group Ltd generates.

  • Above 15 is considered overpriced but always compare China Resources Pharmaceutical Group Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 9.57 means the investor is paying $9.57 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of China Resources Pharmaceutical Group Ltd:

  • The EOD is 7.392. Based on the earnings, the company is cheap. +2
  • The MRQ is 9.574. Based on the earnings, the company is underpriced. +1
  • The TTM is 9.574. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD7.392MRQ9.574-2.181
MRQ9.574TTM9.5740.000
TTM9.574YOY5.918+3.656
TTM9.5745Y10.610-1.036
5Y10.61010Y9.079+1.530
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of China Resources Pharmaceutical Group Ltd:

  • The EOD is 3.103. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 4.019. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 4.019. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.103MRQ4.019-0.916
MRQ4.019TTM4.0190.000
TTM4.019YOY2.129+1.890
TTM4.0195Y5.278-1.259
5Y5.27810Y6.924-1.647
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of China Resources Pharmaceutical Group Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of China Resources Pharmaceutical Group Ltd:

  • The EOD is 0.573. Based on the equity, the company is cheap. +2
  • The MRQ is 0.742. Based on the equity, the company is cheap. +2
  • The TTM is 0.742. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.573MRQ0.742-0.169
MRQ0.742TTM0.7420.000
TTM0.742YOY0.405+0.337
TTM0.7425Y0.604+0.137
5Y0.60410Y0.489+0.115
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of China Resources Pharmaceutical Group Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.245-0.2450%-4.995+1943%-0.466+91%0.852-129%
Book Value Per Share--8.5238.5230%8.767-3%10.684-20%9.247-8%
Current Ratio--1.2501.2500%1.250+0%1.238+1%1.243+1%
Debt To Asset Ratio--0.7950.7950%0.7950%0.700+14%0.677+17%
Debt To Equity Ratio--3.8693.8690%3.8760%3.286+18%3.290+18%
Dividend Per Share--0.1620.1620%0.130+25%0.134+21%0.106+53%
Eps--0.6600.6600%0.600+10%0.588+12%0.524+26%
Free Cash Flow Per Share--1.5731.5730%1.668-6%1.279+23%0.826+90%
Free Cash Flow To Equity Per Share---0.445-0.4450%2.184-120%0.472-194%0.561-179%
Gross Profit Margin--1.0001.0000%1.0000%-2.049+305%-2.317+332%
Intrinsic Value_10Y_max--21.845--------
Intrinsic Value_10Y_min--15.871--------
Intrinsic Value_1Y_max--1.592--------
Intrinsic Value_1Y_min--1.372--------
Intrinsic Value_3Y_max--5.238--------
Intrinsic Value_3Y_min--4.335--------
Intrinsic Value_5Y_max--9.433--------
Intrinsic Value_5Y_min--7.510--------
Market Cap30658647941.120-30%39705466107.20039705466107.2000%22302912136.550+78%39335481524.596+1%31524857396.830+26%
Net Profit Margin--0.0160.0160%0.016+3%0.017-5%0.019-12%
Operating Margin--0.0450.0450%0.042+8%0.050-11%0.056-20%
Operating Ratio--1.7911.7910%1.7990%1.453+23%1.195+50%
Pb Ratio0.573-30%0.7420.7420%0.405+83%0.604+23%0.489+52%
Pe Ratio7.392-30%9.5749.5740%5.918+62%10.610-10%9.079+5%
Price Per Share4.880-30%6.3206.3200%3.550+78%6.260+1%5.017+26%
Price To Free Cash Flow Ratio3.103-30%4.0194.0190%2.129+89%5.278-24%6.924-42%
Price To Total Gains Ratio-59.157+23%-76.613-76.6130%-0.730-99%-20.404-73%-13.195-83%
Quick Ratio--1.1261.1260%1.164-3%1.223-8%1.039+8%
Return On Assets--0.0160.0160%0.014+13%0.016-3%0.019-14%
Return On Equity--0.0770.0770%0.068+13%0.076+2%0.090-14%
Total Gains Per Share---0.082-0.0820%-4.866+5798%-0.332+303%0.958-109%
Usd Book Value--6837568325.9276837568325.9270%7033766895.448-3%8572756422.782-20%7419386222.329-8%
Usd Book Value Change Per Share---0.031-0.0310%-0.638+1943%-0.060+91%0.109-129%
Usd Book Value Per Share--1.0881.0880%1.120-3%1.364-20%1.181-8%
Usd Dividend Per Share--0.0210.0210%0.017+25%0.017+21%0.014+53%
Usd Eps--0.0840.0840%0.077+10%0.075+12%0.067+26%
Usd Free Cash Flow--1261715017.1521261715017.1520%1337848011.237-6%1026451565.610+23%662801619.867+90%
Usd Free Cash Flow Per Share--0.2010.2010%0.213-6%0.163+23%0.105+90%
Usd Free Cash Flow To Equity Per Share---0.057-0.0570%0.279-120%0.060-194%0.072-179%
Usd Market Cap3915109342.081-30%5070388021.8895070388021.8890%2848081879.837+78%5023140990.691+1%4025724289.575+26%
Usd Price Per Share0.623-30%0.8070.8070%0.453+78%0.799+1%0.641+26%
Usd Profit--529624512.400529624512.4000%481287125.300+10%473453777.440+12%421125420.550+26%
Usd Revenue--32449382938.20032449382938.2000%30240147781.300+7%27723121758.360+17%23164574683.940+40%
Usd Total Gains Per Share---0.011-0.0110%-0.621+5798%-0.042+303%0.122-109%
 EOD+5 -3MRQTTM+0 -0YOY+21 -145Y+21 -1510Y+16 -20

3.2. Fundamental Score

Let's check the fundamental score of China Resources Pharmaceutical Group Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-157.392
Price to Book Ratio (EOD)Between0-10.573
Net Profit Margin (MRQ)Greater than00.016
Operating Margin (MRQ)Greater than00.045
Quick Ratio (MRQ)Greater than11.126
Current Ratio (MRQ)Greater than11.250
Debt to Asset Ratio (MRQ)Less than10.795
Debt to Equity Ratio (MRQ)Less than13.869
Return on Equity (MRQ)Greater than0.150.077
Return on Assets (MRQ)Greater than0.050.016
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of China Resources Pharmaceutical Group Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.811
Ma 20Greater thanMa 504.882
Ma 50Greater thanMa 1005.067
Ma 100Greater thanMa 2005.005
OpenGreater thanClose4.780
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets241,286,418
Total Liabilities191,726,999
Total Stockholder Equity49,559,419
 As reported
Total Liabilities 191,726,999
Total Stockholder Equity+ 49,559,419
Total Assets = 241,286,418

Assets

Total Assets241,286,418
Total Current Assets170,451,455
Long-term Assets70,834,963
Total Current Assets
Cash And Cash Equivalents 17,042,657
Short-term Investments 35,038,263
Net Receivables 66,373,478
Other Current Assets 42,164,651
Total Current Assets  (as reported)170,451,455
Total Current Assets  (calculated)160,619,049
+/- 9,832,406
Long-term Assets
Property Plant Equipment 24,732,021
Goodwill 22,847,667
Intangible Assets 8,498,967
Other Assets 7,814,750
Long-term Assets  (as reported)70,834,963
Long-term Assets  (calculated)63,893,405
+/- 6,941,558

Liabilities & Shareholders' Equity

Total Current Liabilities136,319,157
Long-term Liabilities14,784,928
Total Stockholder Equity49,559,419
Total Current Liabilities
Short-term Debt 10,976,172
Short Long Term Debt 40,640,553
Accounts payable 54,531,235
Other Current Liabilities 36,155,209
Total Current Liabilities  (as reported)136,319,157
Total Current Liabilities  (calculated)142,303,169
+/- 5,984,012
Long-term Liabilities
Long term Debt Total 10,984,525
Other Liabilities 3,800,403
Long-term Liabilities  (as reported)14,784,928
Long-term Liabilities  (calculated)14,784,928
+/-0
Total Stockholder Equity
Common Stock27,241,289
Other Stockholders Equity 22,318,130
Total Stockholder Equity (as reported)49,559,419
Total Stockholder Equity (calculated)49,559,419
+/-0
Other
Capital Stock27,241,289
Cash and Short Term Investments 52,080,920
Common Stock Shares Outstanding 6,282,510
Liabilities and Stockholders Equity 241,286,418
Net Debt 33,720,125
Net Invested Capital 100,322,201
Net Tangible Assets 18,242,529
Net Working Capital 34,132,298
Property Plant and Equipment Gross 35,472,711



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
> Total Assets 
104,823,067
121,797,602
127,148,599
133,985,514
160,754,148
176,244,487
190,025,013
209,371,760
248,562,310
241,286,418
241,286,418248,562,310209,371,760190,025,013176,244,487160,754,148133,985,514127,148,599121,797,602104,823,067
   > Total Current Assets 
68,797,831
84,277,191
88,856,877
93,802,413
113,198,523
128,360,065
132,942,616
147,108,857
176,609,609
170,451,455
170,451,455176,609,609147,108,857132,942,616128,360,065113,198,52393,802,41388,856,87784,277,19168,797,831
       Cash And Cash Equivalents 
15,175,387
13,417,624
12,378,606
13,960,197
14,161,833
16,633,301
12,524,016
11,231,497
17,513,134
17,042,657
17,042,65717,513,13411,231,49712,524,01616,633,30114,161,83313,960,19712,378,60613,417,62415,175,387
       Short-term Investments 
1,756,644
5,580,322
6,310,350
3,648,846
6,556,642
28,023,549
26,403,362
34,613,823
40,251,630
35,038,263
35,038,26340,251,63034,613,82326,403,36228,023,5496,556,6423,648,8466,310,3505,580,3221,756,644
       Net Receivables 
35,367,552
43,847,269
35,862,834
52,773,364
64,447,699
53,880,258
84,159,185
66,449,630
66,528,689
66,373,478
66,373,47866,528,68966,449,63084,159,18553,880,25864,447,69952,773,36435,862,83443,847,26935,367,552
       Inventory 
12,198,122
15,711,480
15,251,983
18,859,121
21,406,298
21,527,923
22,332,374
24,584,761
29,687,992
29,718,446
29,718,44629,687,99224,584,76122,332,37421,527,92321,406,29818,859,12115,251,98315,711,48012,198,122
       Other Current Assets 
2,992,739
4,065,408
7,218,342
2,737,392
3,789,845
3,773,984
4,614,611
6,491,930
7,814,631
42,164,651
42,164,6517,814,6316,491,9304,614,6113,773,9843,789,8452,737,3927,218,3424,065,4082,992,739
   > Long-term Assets 
0
0
0
40,183,101
47,555,625
47,884,422
57,082,397
62,262,903
71,952,701
70,834,963
70,834,96371,952,70162,262,90357,082,39747,884,42247,555,62540,183,101000
       Property Plant Equipment 
12,528,162
13,073,816
13,081,371
12,500,077
14,737,651
14,652,228
22,104,517
22,890,016
25,531,736
24,732,021
24,732,02125,531,73622,890,01622,104,51714,652,22814,737,65112,500,07713,081,37113,073,81612,528,162
       Goodwill 
14,892,860
15,321,660
16,394,509
17,404,821
20,544,612
19,804,854
19,306,440
21,072,192
24,901,550
22,847,667
22,847,66724,901,55021,072,19219,306,44019,804,85420,544,61217,404,82116,394,50915,321,66014,892,860
       Long Term Investments 
1,084,253
842,519
589,525
2,072,248
2,535,242
2,500,771
0
0
0
0
00002,500,7712,535,2422,072,248589,525842,5191,084,253
       Intangible Assets 
3,322,027
3,378,474
3,893,795
3,806,670
4,740,460
4,954,664
6,049,195
6,939,633
9,000,511
8,498,967
8,498,9679,000,5116,939,6336,049,1954,954,6644,740,4603,806,6703,893,7953,378,4743,322,027
       Long-term Assets Other 
80,590
44,368
9,300
7,049
34,258
38,375
15,079
2,368,622
1,974,730
2,885
2,8851,974,7302,368,62215,07938,37534,2587,0499,30044,36880,590
> Total Liabilities 
72,174,373
84,647,148
87,303,034
79,683,660
97,616,978
115,715,428
120,443,192
129,342,316
197,580,823
191,726,999
191,726,999197,580,823129,342,316120,443,192115,715,42897,616,97879,683,66087,303,03484,647,14872,174,373
   > Total Current Liabilities 
58,897,907
65,472,488
72,223,796
70,984,637
91,734,395
103,358,369
106,671,669
122,619,655
141,322,576
136,319,157
136,319,157141,322,576122,619,655106,671,669103,358,36991,734,39570,984,63772,223,79665,472,48858,897,907
       Short-term Debt 
1,756,644
5,580,322
6,310,350
3,648,846
6,556,642
28,023,549
26,403,362
40,281,912
0
10,976,172
10,976,172040,281,91226,403,36228,023,5496,556,6423,648,8466,310,3505,580,3221,756,644
       Short Long Term Debt 
31,229,597
19,650,561
21,335,485
19,326,670
33,431,518
40,786,461
29,774,643
40,281,912
47,850,810
40,640,553
40,640,55347,850,81040,281,91229,774,64340,786,46133,431,51819,326,67021,335,48519,650,56131,229,597
       Accounts payable 
24,774,166
30,857,302
33,436,151
39,850,537
42,217,270
39,526,393
42,747,075
45,602,092
52,380,467
54,531,235
54,531,23552,380,46745,602,09242,747,07539,526,39342,217,27039,850,53733,436,15130,857,30224,774,166
       Other Current Liabilities 
13,948,119
13,963,058
12,247,652
9,601,398
13,478,470
15,786,918
16,788,298
20,839,740
23,912,015
36,155,209
36,155,20923,912,01520,839,74016,788,29815,786,91813,478,4709,601,39812,247,65213,963,05813,948,119
   > Long-term Liabilities 
0
0
0
8,699,023
5,882,583
12,357,059
13,771,523
6,722,661
12,255,468
14,784,928
14,784,92812,255,4686,722,66113,771,52312,357,0595,882,5838,699,023000
       Long term Debt Total 
0
0
12,882,853
6,384,762
3,443,652
10,149,668
10,876,407
3,163,509
8,113,091
10,984,525
10,984,5258,113,0913,163,50910,876,40710,149,6683,443,6526,384,76212,882,85300
       Capital Lease Obligations Min Short Term Debt
-1,756,644
-5,580,322
-6,310,350
-3,648,846
-6,556,642
-28,023,549
-24,156,006
-38,416,246
1,515,667
-9,558,668
-9,558,6681,515,667-38,416,246-24,156,006-28,023,549-6,556,642-3,648,846-6,310,350-5,580,322-1,756,644
       Other Liabilities 
1,501,882
1,446,825
2,196,385
2,314,261
2,438,931
2,207,391
2,895,116
3,559,152
4,142,377
3,800,403
3,800,4034,142,3773,559,1522,895,1162,207,3912,438,9312,314,2612,196,3851,446,8251,501,882
       Deferred Long Term Liability 
335,216
264,129
347,317
384,518
577,318
891,435
1,089,653
1,177,835
1,452,889
0
01,452,8891,177,8351,089,653891,435577,318384,518347,317264,129335,216
> Total Stockholder Equity
17,988,255
20,516,319
22,502,235
37,620,345
41,869,799
39,313,022
40,711,348
46,469,826
50,981,487
49,559,419
49,559,41950,981,48746,469,82640,711,34839,313,02241,869,79937,620,34522,502,23520,516,31917,988,255
   Common Stock
4,629,424
12,473,920
12,473,920
27,241,289
27,241,289
27,241,289
27,241,289
27,241,289
27,241,289
27,241,289
27,241,28927,241,28927,241,28927,241,28927,241,28927,241,28927,241,28912,473,92012,473,9204,629,424
   Retained Earnings 
8,234,932
10,880,872
10,204,637
16,552,358
18,801,440
20,385,250
22,785,436
19,228,537
28,396,951
24,813,023
24,813,02328,396,95119,228,53722,785,43620,385,25018,801,44016,552,35810,204,63710,880,8728,234,932
   Capital Surplus 0000000000
   Treasury Stock0000000000
   Other Stockholders Equity 
-2,720,597
-2,838,473
-178,368
-6,173,302
-4,172,930
-8,313,517
-9,315,377
19,228,537
-4,656,753
22,318,130
22,318,130-4,656,75319,228,537-9,315,377-8,313,517-4,172,930-6,173,302-178,368-2,838,473-2,720,597



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in HKD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue254,106,366
Cost of Revenue-214,971,606
Gross Profit39,134,76039,134,760
 
Operating Income (+$)
Gross Profit39,134,760
Operating Expense-240,019,288
Operating Income11,487,186-200,884,528
 
Operating Expense (+$)
Research Development-
Selling General Administrative26,733,016
Selling And Marketing Expenses-
Operating Expense240,019,28826,733,016
 
Net Interest Income (+$)
Interest Income1,631,473
Interest Expense-122,579
Other Finance Cost-3,529,011
Net Interest Income-2,020,117
 
Pretax Income (+$)
Operating Income11,487,186
Net Interest Income-2,020,117
Other Non-Operating Income Expenses-
Income Before Tax (EBT)9,855,71311,487,186
EBIT - interestExpense = 11,317,618
6,159,814
4,269,991
Interest Expense122,579
Earnings Before Interest and Taxes (EBIT)11,440,1979,978,292
Earnings Before Interest and Taxes (EBITDA)15,861,856
 
After tax Income (+$)
Income Before Tax9,855,713
Tax Provision-2,012,402
Net Income From Continuing Ops7,843,3117,843,311
Net Income4,147,412
Net Income Applicable To Common Shares4,147,412
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses2,152,545
Total Other Income/Expenses Net-2,020,117
 

Technical Analysis of China Resources Pharmaceutical Group Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of China Resources Pharmaceutical Group Ltd. The general trend of China Resources Pharmaceutical Group Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine China Resources Pharmaceutical Group Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of China Resources Pharmaceutical Group Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.3 < 5.3 < 5.34.

The bearish price targets are: 4.65 > 4.62 > 4.56.

Tweet this
China Resources Pharmaceutical Group Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of China Resources Pharmaceutical Group Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

China Resources Pharmaceutical Group Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of China Resources Pharmaceutical Group Ltd. The current macd is -0.08325251.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the China Resources Pharmaceutical Group Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for China Resources Pharmaceutical Group Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the China Resources Pharmaceutical Group Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
China Resources Pharmaceutical Group Ltd Daily Moving Average Convergence/Divergence (MACD) ChartChina Resources Pharmaceutical Group Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of China Resources Pharmaceutical Group Ltd. The current adx is 20.42.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell China Resources Pharmaceutical Group Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
China Resources Pharmaceutical Group Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of China Resources Pharmaceutical Group Ltd. The current sar is 4.631088.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
China Resources Pharmaceutical Group Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of China Resources Pharmaceutical Group Ltd. The current rsi is 48.81. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
China Resources Pharmaceutical Group Ltd Daily Relative Strength Index (RSI) ChartChina Resources Pharmaceutical Group Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of China Resources Pharmaceutical Group Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the China Resources Pharmaceutical Group Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
China Resources Pharmaceutical Group Ltd Daily Stochastic Oscillator ChartChina Resources Pharmaceutical Group Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of China Resources Pharmaceutical Group Ltd. The current cci is -22.27505944.

China Resources Pharmaceutical Group Ltd Daily Commodity Channel Index (CCI) ChartChina Resources Pharmaceutical Group Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of China Resources Pharmaceutical Group Ltd. The current cmo is 4.0196315.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
China Resources Pharmaceutical Group Ltd Daily Chande Momentum Oscillator (CMO) ChartChina Resources Pharmaceutical Group Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of China Resources Pharmaceutical Group Ltd. The current willr is -42.22222222.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that China Resources Pharmaceutical Group Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
China Resources Pharmaceutical Group Ltd Daily Williams %R ChartChina Resources Pharmaceutical Group Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of China Resources Pharmaceutical Group Ltd.

China Resources Pharmaceutical Group Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of China Resources Pharmaceutical Group Ltd. The current atr is 0.15497024.

China Resources Pharmaceutical Group Ltd Daily Average True Range (ATR) ChartChina Resources Pharmaceutical Group Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of China Resources Pharmaceutical Group Ltd. The current obv is 345,906,205.

China Resources Pharmaceutical Group Ltd Daily On-Balance Volume (OBV) ChartChina Resources Pharmaceutical Group Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of China Resources Pharmaceutical Group Ltd. The current mfi is 46.76.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
China Resources Pharmaceutical Group Ltd Daily Money Flow Index (MFI) ChartChina Resources Pharmaceutical Group Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for China Resources Pharmaceutical Group Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

China Resources Pharmaceutical Group Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of China Resources Pharmaceutical Group Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.811
Ma 20Greater thanMa 504.882
Ma 50Greater thanMa 1005.067
Ma 100Greater thanMa 2005.005
OpenGreater thanClose4.780
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of China Resources Pharmaceutical Group Ltd with someone you think should read this too:
  • Are you bullish or bearish on China Resources Pharmaceutical Group Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about China Resources Pharmaceutical Group Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about China Resources Pharmaceutical Group Ltd

I send you an email if I find something interesting about China Resources Pharmaceutical Group Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about China Resources Pharmaceutical Group Ltd.

Receive notifications about China Resources Pharmaceutical Group Ltd in your mailbox!